FutureBio Saudi Company
Future Biopharma KSA is a rapidly expanding pharmaceutical company based in Jeddah, Saudi Arabia. A proud subsidiary of Nahran, it specializes in Contract Development and Manufacturing Organization (CDMO), biological products sector focusing on blood derivatives, vaccines, and Biosimilars. The company aims to contribute to the advancement of local healthcare and pharmaceutical industries, aligning with the 2030 Saudi Vision.
Technology:
Biopharma & Life Science Tools
Employee Number:
51-100
Headquarters:
Jeddah, Saudi Arabia
Founded Date:
2013
Industry:
CRO, CDMO & Bioprocessing
Country:
Saudi Arabia
City:
Jeddah
Founders:
Nahran group
Investors:
Saudi National Bank, Al-Rajhi Bank, Aramco
Company Type:
Private